Massimo Andreatta

18PUBLICATIONS
82CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsSequence analysisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Mar 26, 2026
Enhancing Proteasome Activity in T Cells Alleviates Exhaustion and Improves Antitumor Immunity.

Ander de Blas, Massimo Andreatta, Asier Antoñana-Vildosola

|Aug 22, 2025
Identification of malignant cells in single-cell transcriptomics data.

Massimo Andreatta, Josep Garnica, Santiago Javier Carmona

|May 20, 2025
Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure.

Helen Carrasco Hope, Jana de Sostoa, Pierpaolo Ginefra

|Jan 29, 2024
Semi-supervised integration of single-cell transcriptomics data.

Massimo Andreatta, Léonard Hérault, Paul Gueguen

|Jan 03, 2024
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases.

Yang Zhao, Jiangqing Chen, Massimo Andreatta

|Sep 14, 2023
Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8+ T cell exhaustion.

Laure Tillé, Daniela Cropp, Mélanie Charmoy

Pageof 3